Jan Östergren

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jan Östergren är professor emeritus i medicin. Hans forskning handlar framför allt om angiologi, det vill säga vaskulär medicin och hypertoni/högt blodtryck.

Artiklar

Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2023;57(1):2236341

Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation

Klaveback S; Skuladottir H; Olbers J; Ostergren J; Braunschweig F
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. HYPERTENSION. 2021;8:100074

Ambulatory blood pressure monitoring and blood pressure control in patients with coronary artery disease-A randomized controlled trial

Hagglund O; Svensson P; Linde C; Ostergren J
Article: JOURNAL OF HYPERTENSION. 2021;39(2):243-249

Changes in 24-h ambulatory blood pressure following restoration of sinus rhythmin patients with atrial fibrillation

Olbers J; Ostergren J; Rosenqvist M; Skuladottir H; Klaveback S; Ljungman P; Witt N
Article: ANNALS OF EMERGENCY MEDICINE. 2019;74(3):345-356

Associations Between Crowding and Ten-Day Mortality Among Patients Allocated Lower Triage Acuity Levels Without Need of Acute Hospital Care on Departure From the Emergency Department

Berg LM; Ehrenberg A; Florin J; Ostergren J; Discacciati A; Goransson KE
Article: JMIR MEDICAL EDUCATION. 2019;5(2):e12791

Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource: Mixed Methods Study.

Nilsson M; Fors U; Östergren J; Bolinder G; Edelbring S
Article: INTERNATIONAL EMERGENCY NURSING. 2019;43:50-55

Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital

Berg LM; Ehrenberg A; Florin J; Ostergren J; Goransson KE
Article: JOURNAL OF CLINICAL HYPERTENSION. 2019;21(3):363-368

Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion

Olbers J; Jacobson E; Viberg F; Witt N; Ljungman P; Rosenqvist M; Ostergren J
Article: BLOOD PRESSURE. 2018;27(5):249-255

High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm

Olbers J; Gille A; Ljungman P; Rosenqvist M; Ostergren J; Witt N
Article: INTERNATIONAL EMERGENCY NURSING. 2017;33:14-19

Physicians' and nurses' perceptions of patient safety risks in the emergency department

Kallberg A-S; Ehrenberg A; Florin J; Ostergren J; Goransson KE
Article: NEONATOLOGY. 2017;112(1):87-91

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm

Kistner A; Jacobson L; Ostergren J; Hellstrom A
Article: INTERNATIONAL EMERGENCY NURSING. 2016;29:21-26

Reasons for interrupting colleagues during emergency department work - A qualitative study

Berg LM; Florin J; Ehrenberg A; Ostergren J; Djarv T; Goransson KE
Article: BLOOD PRESSURE. 2016;25(5):286-291

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease

Hagglund O; Sjoqvist I; Linde C; Svensson P; Ostergren J
Article: INTERNATIONAL EMERGENCY NURSING. 2016;27:11-16

Factors influencing clinicians' perceptions of interruptions as disturbing or non-disturbing: A qualitative study

Berg LM; Kallberg A-S; Ehrenberg A; Florin J; Ostergren J; Djarv T; Brixey JJ; Goransson KE
Journal article: CIRCULATION. 2015;132(suppl_3)

Abstract 16891: Beat-to-beat Systolic as Well as Diastolic Blood Pressure Variability is High in Atrial Fibrillation

Olbers J; Gille A; Östergren J; Ljungman P; Rosenqvist M; Witt N
Article: INTERNATIONAL EMERGENCY NURSING. 2015;23(2):156-161

Contributing factors to errors in Swedish emergency departments

Kallberg A-S; Goransson KE; Florin J; Ostergren J; Brixey JJ; Ehrenberg A
Article: JOURNAL OF CLINICAL HYPERTENSION. 2015;17(2):141-146

Amlodipine plus Benazepril is Superior to Hydrochlorothiazide plus Benazepril Irrespective of Baseline Pulse Pressure: Subanalysis of the ACCOMPLISH Trial

Skoglund PH; Svensson P; Asp J; Dahlof B; Kjeldsen SE; Jamerson KA; Weber MA; Jia Y; Zappe DH; Ostergren J
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2014;11(3):133-173

ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary

Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Sousa M; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Luis Zamorano J; Luis Zamorano J; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Luis Tamargo J; Tendera M; Torbicki A; Wijns W; Windecker S; De Backer G; Sirnes PA; Alegria Ezquerra E; Avogaro A; Badimon L; Baranova E; Baumgartner H; Betteridge J; Ceriello A; Fagard R; Funck-Brentano C; Gulba DC; Hasdai D; Hoes AW; Kjekshus JK; Knuuti J; Kolh P; Lev E; Mueller C; Neyses L; Nilsson PM; Perk J; Ponikowski P; Reiner Z; Sattar N; Schaechinger V; Scheen A; Schirmer H; Stromberg A; Sudzhaeva S; Luis Tamargo J; Viigimaa M; Vlachopoulos C; Xuereb RG
Article: AMERICAN JOURNAL OF HYPERTENSION. 2014;27(3):363-371

Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein but Not Cystatin C Predict Cardiovascular Events in Male Patients with Peripheral Artery Disease Independently of Ambulatory Pulse Pressure

Skoglund PH; Arpegard J; Ostergren J; Svensson P
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16(1):33-40

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

Rogers JK; Pocock SJ; McMurray JJV; Granger CB; Michelson EL; Ostergren J; Pfeffer MA; Solomon SD; Swedberg K; Yusuf S
Article: EUROPEAN HEART JOURNAL. 2013;34(39):3035-3087

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
Article: BMJ QUALITY & SAFETY. 2013;22(8):656-663

Interruptions in emergency department work: an observational and interview study

Berg LM; Kallberg A-S; Goransson KE; Ostergren J; Florin J; Ehrenberg A
Article: JOURNAL OF HYPERTENSION. 2013;31(7):1281-1357

2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC)

Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Boehm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Fagard DH; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Ryden L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Article: EUROPEAN JOURNAL OF EMERGENCY MEDICINE. 2013;20(1):33-38

Medical errors and complaints in emergency department care in Sweden as reported by care providers, healthcare staff, and patients - a national review

Kallberg A-S; Goransson KE; Ostergren J; Florin J; Ehrenberg A
Article: KARDIOLOGIA POLSKA. 2013;71:S319-S394

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
Article: EUROPEAN JOURNAL OF EMERGENCY MEDICINE. 2012;19(4):246-251

An observational study of activities and multitasking performed by clinicians in two Swedish emergency departments

Berg LM; Ehrenberg A; Florin J; Ostergren J; Goransson KE
Article: BLOOD PRESSURE. 2012;21(4):227-232

Ambulatory pulse pressure predicts cardiovascular events in patients with peripheral arterial disease

Skoglund PH; Ostergren J; Svensson P
Article: ANNALS OF MEDICINE. 2012;44(3):262-270

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

Holzmann MJ; Jungner I; Walldius G; Ivert T; Nordqvist T; Ostergren J; Hammar N
Article: BLOOD PRESSURE. 2012;21(2):82-87

Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study

Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlof B; Velazquez EJ; Hua TA; Kelly RY; Zappe D; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M
Article: TURK KARDIYOLOJI DERNEGI ARSIVI. 2012;40 Suppl 1:5-60

[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries].

Tendera M; Aboyans V; Bartelink L; Baumgartner I; Clement D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Rother J; Sievert H; van Sambeek M; Zeller T; Avrupa Kardiyoloji Derneği ESC Periferik Atardamar; Avrupa Inme Organizasyonu (ESO) tarafindan destekl
Article: BMC MEDICAL EDUCATION. 2012;12:5

Does individual learning styles influence the choice to use a web-based ECG learning programme in a blended learning setting?

Nilsson M; Ostergren J; Fors U; Rickenlund A; Jorfeldt L; Caidahl K; Bolinder G
Article: EUROPEAN HEART JOURNAL. 2011;32(22):2851-2906

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)

Tendera M; Aboyans V; Bartelink M-L; Baumgartner I; Clement D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Roether J; Sievert H; van Sambeek M; Zeller T; Bax J; Auricchio A; Baumgartner H; Ceconi C; Dean V; Deaton C; Fagard R; Funck-Brentano C; Hasdai D; Hoes A; Knuuti J; Kolh P; McDonagh T; Moulin C; Poldermans D; Popescu B; Reiner Z; Sechtem U; Sirnes PA; Torbicki A; Vahanian A; Windecker S; Agewall S; Blinc A; Bulvas M; Cosentino F; De Backer T; Gottsater A; Gulba D; Guzik TJ; Jonsson B; Kesmarky G; Kitsiou A; Kuczmik W; Larsen ML; Madaric J; Mas J-L; McMurray JJV; Micari A; Mosseri M; Muller C; Naylor R; Norrving B; Oto O; Pasierski T; Plouin P-F; Ribichini F; Ricco J-B; Ruilop L; Schmid J-P; Schwehr U; Sol BGM; Sprynger M; Tiefenbacher C; Tsioufis C; Van Damme H
Article: AMERICAN HEART JOURNAL. 2011;162(5):900-906

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Ariti CA; Cleland JGF; Pocock SJ; Pfeffer MA; Swedberg K; Granger CB; McMurray JJV; Michelson EL; Ostergren J; Yusuf S
Article: INTERNATIONAL ANGIOLOGY. 2011;30(2):150-155

The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia

Belch JJF; Ray S; Rajput-Ray M; Engeset J; Fagrell B; Lepantalo M; Mckay A; Mackay IR; Ostergren J; Ruckley CV; Salenius J
Journal article: AUSTRALASIAN EMERGENCY CARE. 2011;14:s21

Multitasking and interruptions of emergency department clinicians’ activities

Berg LM; Ehrenberg A; Östergren J; Florin J; Göransson KE
Journal article: AUSTRALASIAN EMERGENCY CARE. 2011;14:s18

Medical errors regarding emergency department care reported to national authorities in Sweden by care providers and patients

Källberg A-S; Ehrenberg A; Östergren J; Florin J; Göransson KE
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2010;44(6):325-330

Change in blood pressure during hospitalisation for acute heart failure predicts mortality

Svensson P; Sundberg H; Lund LH; Ostergren J
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2010;12(6):557-565

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme

Hawkins NM; Wang D; Petrie MC; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Solomon SD; Ostergren J; Michelson EL; Pocock SJ; Maggioni AP; McMurray JJV
Article: JOURNAL OF INTERNAL MEDICINE. 2010;267(4):357-369

Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and women

Holzmann MJ; Ivert T; Jungner I; Nordqvist T; Walldius G; Ostergren J; Hammar N
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(11):1092-1098

Adherence to medication according to sex and age in the CHARM programme

Granger BB; Ekman I; Granger CB; Ostergren J; Olofsson B; Michelson E; McMurray JJV; Yusuf S; Pfeffer MA; Swedberg K
Article: JOURNAL OF INTERNAL MEDICINE. 2009;266(5):457-466

Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment

Malmstrom RE; Orstergren J; Jorgensen L; Hjemdahl P
Article: LAKARTIDNINGEN. 2009;106(38):2354-2356

[Variation of internship test results depends on the seat of learning and age. Analysis of tests 1995-2008].

Ostergren J; Kaviani C; Thorvaldsen T; Krook-Brandt M; Dahlgren L-O
Article: DIABETES CARE. 2009;32(5):915-920

Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Preiss D; Zetterstrand S; McMurray JJV; Ostergren J; Michelson EL; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; Gerstein HC; Sattar N
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2008;52(24):2000-2007

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Meredith PA; Ostergren J; Anand I; Puu M; Solomon SD; Michelson EL; Olofsson B; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; McMurray JJV
Article: JOURNAL OF HYPERTENSION. 2008;26(11):2103-2111

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

Ostergren J; Poulter NR; Sever PS; Dahlof B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E
Article: EUROPEAN HEART JOURNAL. 2008;29(21):2641-2650

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

Pocock SJ; McMurray JJV; Dobson J; Yusuf S; Granger CB; Michelson EL; Oestergren J; Pfeffer MA; Solomon SD; Anker SD; Swedberg KB
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2008;102(6):733-737

Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction

Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Article: ATHEROSCLEROSIS. 2008;199(2):397-401

Cystatin C -: A marker of peripheral atherosclerotic disease?

Arpegard J; Oestergren J; de Faire U; Hansson L-O; Svensson P
Article: EUROPEAN HEART JOURNAL. 2008;29(11):1377-1385

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

MacDonald MR; Petrie MC; Varyani F; Ostergren J; Michelson EL; Young JB; Solomon SD; Granger CB; Swedberg K; Yusuf S; Pfeffer MA; McMurray JJV
Article: BMC MEDICAL EDUCATION. 2008;8:25

Evaluation of a web-based ECG-interpretation programme for undergraduate medical students

Nilsson M; Bolinder G; Held C; Johansson B-L; Fors U; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2008;29(4):499-508

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm:: extended observations 2 years after trial closure

Sever PS; Poulter NR; Dahlof B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes G; Mehlsen J; Nieminen MS; O'Brien ET; Ostergren J
Article: BLOOD PRESSURE. 2008;17(1):7-17

Predictors of blood pressure response to intensified and fixed combination treatment of hypertension:: The ACCOMPLISH Study

Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlof B; Velazquez EJ; Gupte J; Staikos L; Hua TA; Shi V; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M
Article: CIRCULATION. 2007;115(24):3111-3120

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure - Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

O'Meara E; Clayton T; McEntegart MB; McMurray JJV; Pina IL; Granger CB; Ostergren J; Michelson EL; Solomon SD; Pocock S; Yusuf S; Swedberg K; Pfeffer MA
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2007;60(5):1e-64e

[Guidelines on diabetes, pre-diabetes, and cardiovascular diseases].

Grupo de Trabajo sobre Diabetes y Enfermedades Car; Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2007;9(5):510-517

Prevalence and prognostic impact of bundle branch block in patients with heart failure:: Evidence from the CHARM programme

Hawkins NM; Wang D; McMurray JJV; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007;49(6):687-694

Diastolic dysfunction in heart failure with preserved systolic function:: Need for objective evidence -: Results from the CHARM echocardiographic Substudy CHARMES

Persson H; Lonn E; Edner M; Baruch L; Lang CC; Morton JJ; Ostergren J; McKelvie RS
Article: HEART. 2007;93(1):59-64

Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure:: evidence from the CHARM programme

Hawkins NM; Wang D; McMurray JJV; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2007;27(1):30-35

Myocardial ischaemia in patients with peripheral arterial disease

Svensson P; de Faire U; Niklasson U; Ostergren J
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2006;7:S1-S7

Clinical evidence for the cardiovascular benefits of angiotensin receptor Blockers

Nickenig G; Ostergren J; Struijker-Boudier H
Article: EUROPEAN HEART JOURNAL. 2006;27(12):1447-1458

Resource utilization and costs in the Candesartan in Heart failure:: Assessment of Reduction in Mortality and morbidity (CHARM) programme

McMurray JJV; Andersson FL; Stewart S; Svensson K; Solal AC; Dietz R; Vanhaecke J; van Veldhuisen DJ; Östergren J; Granger CB; Yusuf S; Pfeffer MA; Swedberg K
Article: AMERICAN HEART JOURNAL. 2006;151(5):985-991

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the candesartan in heart failure:: Assessment of reduction in mortality and morbidity (CHARM)-Added trial

McMurray JJV; Young JB; Dunlap ME; Granger CB; Hainer J; Michelson EL; Earle S; Olofsson B; Östergren J; Yusuf S; Swedberg K; Pfeffer MA
Article: CIRCULATION. 2006;113(7):986-994

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure -: Results of the Candesartan in Heart Failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) Program

O'Meara E; Clayton T; McEntegart MB; McMurray JJV; Lang CC; Roger SD; Young JB; Solomon SD; Granger CB; Östergren J; Olofsson B; Michelson EL; Pocock S; Yusuf S; Swedberg K; Pfeffer MA
Article: CIRCULATION. 2006;113(5):671-678

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJV; Yusuf S; Granger CB; Michelson EL; Östergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2006;5(1):120

544 Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: a post‐hoc analysis of the CHARM‐Added trial

McMurray JJV; Granger CB; Michelson EL; Olofsson B; Ostergren J; Yusuf S; Swedberg K; Pfeffer MA; Investigators OBOTC
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2006;5(1):124

555 Indirect comparison of the effects of adding an aldosterone antagonist or an angiotensin receptor blocker in severe heart failure: new data from the CHARM‐Added trial

Weir RAP; McMurray JJV; Granger CB; Olofsson B; Ostergren J; Yusuf S; Swedberg K; Pfeffer MA; Investigators OBOTC
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2006;5(1):30

119 Blood pressure in acute heart failure: relation to mortality at follow up

Sundberg H; Svensson P; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2006;27(1):65-75

Predictors of mortality and morbidity in patients with chronic heart failure

Pocock SJ; Wang DL; Pfeffer MA; Yusuf S; McMurray JJV; Swedberg KB; Östergren J; Michelson EL; Pieper KS; Granger CB
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2005;294(14):1794-1798

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

Demers C; McMurray JJV; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Östergren J; Michelson EL; Johansson PA; Wang DL; Yusuf S
Article: LANCET. 2005;366(9489):907-913

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Poulter NR; Wedel H; Dahlöf B; Sever PS; Beevers DG; Caulfield M; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J; Pocock S
Article: LANCET. 2005;366(9489):895-906

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial

Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J
Article: CIRCULATION. 2005;112(1):48-53

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.

Yusuf S; Ostergren JB; Gerstein HC; Pfeffer MA; Swedberg K; Granger CB; Olofsson B; Probstfield J; McMurray JV; Candesartan in Heart Failure-Assessment of Reducti
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2005;4(1):92

408 Incremental benefit of candesartan in heart failure ‐ new analyses of CHARM‐Added, according to baseline treatment

McMurray JJV; Ostergren J; Held P; Michelson EL; Olofsson B; Granger C; Yusuf S; Pfeffer MA; Swedberg K
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2005;7(4):650-656

Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

O'Meara E; Lewis E; Granger C; Dunlap ME; McKelvie RS; Probstfield JL; Young JB; Michelson EL; Ostergren J; Carlsson J; Olofsson B; McMurray J; Yusuf S; Swedberg K; Pfeffer MA
Article: DIABETES CARE. 2005;28(5):1151-1157

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes:: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Sever PS; Poulter NR; Dahlöf B; Wedel H; Collins R; Beevers G; Caulfield M; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Journal article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2005;12(1):75-81

Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial

Dagenais GR; Yi Q; Lonn E; Sleight P; Ostergren J; Yusuf S
Article: JOURNAL OF CARDIOVASCULAR RISK. 2005;12(1):75-81

Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial

Dagenais GR; Yi OL; Lonn E; Sleight P; Ostergren J; Yusuf S
Article: BLOOD PRESSURE. 2005;14(2):99-106

Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease

Svensson P; De Faire U; Niklasson U; Hansson LO; Östergren J
Article: CIRCULATION. 2004;110(17):2618-2626

Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials

Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJV; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K
Article: JOURNAL OF HUMAN HYPERTENSION. 2004;18(3):193-200

Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls

Svensson P; de Faire U; Niklasson U; Östergren J
Article: EUROPEAN HEART JOURNAL. 2004;25(1):17-24

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

Östergren J; Sleight P; Dagenais G; Danisa K; Bosch J; Yi QL; Yusuf S
Article: LANCET. 2003;362(9386):777-781

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial

Yusuf S; Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJV; Michelson EL; Olofsson B; Östergren J
Article: LANCET. 2003;362(9386):772-776

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial

Granger CB; McMurray JJV; Yusuf S; Held P; Michelson EL; Olofsson B; Östergren J; Pfeffer MA; Swedberg K
Article: LANCET. 2003;362(9386):767-771

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial

McMurray JJV; Östergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA
Article: LANCET. 2003;362(9386):759-766

Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme

Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJV; Michelson EL; Olofsson B; Östergren J; Yusuf S
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2003;4(3):171-175

Angiotensin receptor blockers in heart failure

Östergren J; McMurray JJV
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2003;2(1):129

590 How do men and women with chronic heart failure differ? Baseline demographics from CHARM

McMurray J; Granger C; Held P; Olofsson B; Pfeffer M; Swedberg K; Yusuf S; Östergren J; Michelson E
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2003;2(1):130

594 Differences between diabetic and non‐diabetic patients with chronic heart failure. Baseline demographics from CHARM

Östergren J; Granger C; Held P; Olofsson B; Pfeffer M; McMurray J; Swedberg K; Yusuf S; Michelson E
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2003;2(1):128

588 Differences between younger and older patients with chronic heart failure. Baseline demographics from CHARM

Swedberg K; Granger C; Held P; Olofsson B; McMurray J; Pfeffer M; Yusuf S; Östergren J; Michelson E
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2003;5(3):261-270

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure:: baseline characteristics of patients in the Candesartan in Heart failure -: Assessment of Reduction in Mortality and morbidity (CHARM) programme

McMurray J; Östergren J; Pfeffer M; Swedberg K; Granger C; Yusuf S; Held P; Michelson E; Olofsson B
Article: LANCET. 2003;361(9364):1149-1158

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2002;22(6):370-374

Skin microvascular dilatation response to acetylcholine and sodium nitroprusside in peripheral arterial disease

Jägrén C; Gazelius B; Ihrman-Sandal C; Lindblad LE; Östergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2002;251(6):508-517

The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events:: a Swedish sub-study to the HOPE study

Björholt I; Andersson FL; Kahan T; Östergren J
Article: BMJ-BRITISH MEDICAL JOURNAL. 2002;324(7339):699-702

Use of ramipril in preventing stroke: double blind randomised trial

Bosch J; Yusuf S; Pogue J; Sleight P; Lonn E; Rangoonwala B; Davies R; Ostergren J; Probstfield J
Article: HYPERTENSION. 2001;38(6):E28-E32

Comparative effects of ramipril on ambulatory and office blood pressures -: A HOPE substudy

Svensson P; de Faire U; Sleight P; Yusuf S; Östergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;250(5):398-405

Episodes of ST-segment depression is related to changes in ambulatory blood pressure and heart rate in intermittent claudication

Svensson P; Niklasson U; Östergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;250(5):390-397

Asymptomatic versus symptomatic persistent atrial fibrillation:: clinical and noninvasive characteristics

Frykman V; Frick M; Jensen-Urstad M; Östergren J; Rosenqvist M
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2001;55(7):449-457

What is the relevance of the hope study in general practice?

Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Östergren J; Palma-Gámiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15:S11-S12

Anglo-Scandinavian Cardiac Outcomes Trial:: a brief history, rationale and outline protocol

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1167-1176

Regression of left ventricular hypertrophy in human hypertension with irbesartan

Malmqvist K; Kahan T; Edner M; Held C; Hägg A; Lind L; Müller-Brunotte R; Nyström F; Öhman KP; Osbakken MD; Östergren J
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1139-1147

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Article: CLINICAL CARDIOLOGY. 2001;24(3):238-244

Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation

Frick M; Frykman V; Jensen-Urstad M; Östergren J; Rosenqvist M
Article: JOURNAL OF HYPERTENSION. 2001;19(2):311-317

Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension

Malmqvist K; Isaksson H; Östergren J; Kahan T
Article: BLOOD PRESSURE. 2001;10(2):101-110

Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism

Malmqvist K; Kahan T; Isaksson H; Östergren J
Article: EUROPEAN HEART JOURNAL. 2000;21(14):1177-1185

The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation

Frick M; Darpo B; Östergren J; Rosenqvist M
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 2000;13(S2):32a

Regression of left ventricular mass is not related to glucose and lipid metabolism in human hypertension

Malmqvist K; Kahan T; Isaksson H; Östergren J
Journal article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 2000;4(2):46

Cilostazol improved walking distances and was safe in patients with intermittent claudication

Östergren J
Article: BLOOD PRESSURE. 2000;9(6):340-345

Less difference between office and ambulatory blood pressure in women than in men both before and during antihypertensive treatment

Nyström FH; Öhman KP; Isaksson H; Schwan Å; Östergren J
Article: LAKARTIDNINGEN. 1999;96(48):5326-5327

[Is it time to reconsider the guidelines for hypertension therapy? Several new international recommendations published].

Ostergren J
Journal article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1999;3(4):95

Patients with PVD had greater risks of major perioperative complications associated with myocardial revascularization than patients without PVD

Östergren J
Article: JOURNAL OF CARDIAC FAILURE. 1999;5(3):276-282

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.

Swedberg K; Pfeffer M; Granger C; Held P; McMurray J; Ohlin G; Olofsson B; Ostergren J; Yusuf S
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1999;84(1):104-108

Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation

Frick M; Östergren J; Rosenqvist M
Article: DIABETES CARE. 1999;22(1):147-151

Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers

Kalani M; Brismar K; Fagrell B; Östergren J; Jörneskog G
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1998;32(5):753-759

Adrenaline responsiveness in mild hypertension:: No evidence for altered β-adrenoceptor sensitivity

Kahan T; Hjemdahl P; Lindvall K; Östergren J; de Faire U
Article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1998;2(3):82

Urokinase reduced the need for open surgical procedures in acute ischemia of the leg.

Ostergren J
Article: LAKARTIDNINGEN. 1998;95(32-33):3380-3381

[New discoveries on target blood pressure and ACE inhibitors. Swedish guidelines on hypertension are still correct].

Ostergren J
Article: AMERICAN JOURNAL OF HYPERTENSION. 1998;11(6):690-696

Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension

Östergren J; Isaksson H; Brodin U; Schwan Å; Öhman KP
Article: JOURNAL OF HYPERTENSION. 1997;15(11):1327-1335

Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being

Dahlof B; Lindholm LH; Carney S; Pentikainen PJ; Ostergren J
Article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1997;1(2):38

Ankle brachial index is a predictor of 5-year cardiovascular events.

Ostergren J
Article: BLOOD PRESSURE. 1996;5(1):41-49

Quality of life in hypertensive patients treated with either carvedilol or enalapril.

Ostergren J; Storstein L; Karlberg BE; Tibblin G
Journal article: LAKARTIDNINGEN. 1993;90(32-33):2653-2654

[Do ACE inhibitors potentiate snake venom? Severe and prolonged hypotension caused by adder bite].

Svensson P; Rosenberg J; Ostergren J; Karlson-Stiber C
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1989;8(3):237-244

SKIN CAPILLARY BLOOD-CELL VELOCITY IN PREECLAMPSIA - THE EFFECT OF PLASMA EXPANSION

ROSEN L; OSTERGREN J; FAGRELL B; STRANDEN E
Journal article: MICROVASCULAR RESEARCH. 1989;37(3):289-297

BILATERAL INVOLVEMENT AND THE EFFECT OF SYMPATHETIC BLOCKADE ON SKIN MICROCIRCULATION IN THE SYMPATHETIC DYSTROPHIES

ROSEN L; OSTERGREN J; ROALD OK; STRANDEN E; FAGRELL B
Journal article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1988;18(3):305-308

SKIN MICROVASCULAR CIRCULATION IN THE SYMPATHETIC DYSTROPHIES EVALUATED BY VIDEOPHOTOMETRIC CAPILLAROSCOPY AND LASER DOPPLER FLUXMETRY

ROSEN L; OSTERGREN J; FAGRELL B; STRANDEN E
Journal article: INTERNATIONAL ANGIOLOGY. 1988;7(1):37-41

EVALUATION OF A LASER DOPPLER MULTIPROBE FOR DETECTING SKIN MICROCIRCULATORY DISTURBANCES IN PATIENTS WITH OBLITERATIVE ARTERIOSCLEROSIS

OSTERGREN J; SCHOPS P; FAGRELL B
Journal article: DIABETES RES. 1987;5(4):189-192

Skin microvascular blood flow control in long duration diabetics with and without complications.

Tooke JE; Ostergren J; Lins PE; Fagrell B
Journal article: ACTA MEDICA SCANDINAVICA. 1986;220(5):485-488

ACRODERMATITIS CHRONICA ATROPHICANS HERXHEIMER CAN OFTEN MIMIC A PERIPHERAL VASCULAR DISORDER

FAGRELL B; STIERNSTEDT G; OSTERGREN J
Journal article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1986;8:S119-S121

ADRENALINE RESPONSIVENESS IN BORDERLINE HYPERTENSION

HJEMDAHL P; LINDVALL K; KAHAN T; DEFAIRE U; OSTERGREN J
Journal article: VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. 1986;15(1):56-60

PGE1 TREATMENT OF SEVERE SKIN ISCHEMIA IN PATIENTS WITH PERIPHERAL ARTERIAL INSUFFICIENCY - THE EFFECT ON SKIN MICROCIRCULATION

FAGRELL B; LUNDBERG G; OLSSON A; OSTERGREN J
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1986;5(1):37-51

SKIN CAPILLARY BLOOD-CELL VELOCITY IN MAN - CHARACTERISTICS AND REPRODUCIBILITY OF THE REACTIVE HYPEREMIA RESPONSE

OSTERGREN J; FAGRELL B
Journal article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 1985;5(1):35-43

SKIN CAPILLARY BLOOD-CELL VELOCITY IN PATIENTS WITH ARTERIAL OBLITERATIVE DISEASE AND POLYCYTHEMIA - A DISTURBED REACTIVE HYPEREMIA RESPONSE

OSTERGREN J; FAGRELL B
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1985;4(3):249-256

SKIN MICROVASCULAR AUTOREGULATORY RESPONSES IN TYPE-I DIABETES - THE INFLUENCE OF DURATION AND CONTROL

TOOKE JE; LINS PE; OSTERGREN J; FAGRELL B
Journal article: ACTA PHYSIOLOGICA. 1984;121(2):165-171

THEOPHYLLINE ANTAGONIZES CARDIOVASCULAR-RESPONSES TO DIPYRIDAMOLE IN MAN WITHOUT AFFECTING INCREASES IN PLASMA ADENOSINE

SOLLEVI A; OSTERGREN J; FAGRELL B; HJEMDAHL P
Journal article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 1984;4(2):169-176

VIDEOPHOTOMETRIC CAPILLAROSCOPY FOR EVALUATING DRUG EFFECTS ON SKIN MICROCIRCULATION - A DOUBLE-BLIND-STUDY WITH NIFEDIPINE

OSTERGREN J; FAGRELL B
Journal article: ACTA MEDICA SCANDINAVICA, SUPPLEMENT. 1984;687:25-28

VITAL CAPILLARY MICROSCOPY FOR ASSESSMENT OF SKIN VIABILITY AND MICROANGIOPATHY IN PATIENTS WITH DIABETES-MELLITUS

FAGRELL B; HERMANSSON IL; KARLANDER SG; OSTERGREN J
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1983;2(4):277-284

SYNCHRONOUS ASSESSMENT OF HUMAN-SKIN MICROCIRCULATION BY LASER DOPPLER FLOWMETRY AND DYNAMIC CAPILLAROSCOPY

TOOKE JE; OSTERGREN J; FAGRELL B
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1983;2(4):315-324

THE INFLUENCE OF VENOUS AND ARTERIAL-OCCLUSION ON CAPILLARY BLOOD-FLOW AND TRANS-CUTANEOUS OXYGEN-TENSION IN FINGERS

OSTERGREN J; SVEDMAN P; FAGRELL B
Journal article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1982;13(Suppl 2):S233-S235

EFFECT OF INTRAVENOUSLY ADMINISTERED PINDOLOL ON SKIN CAPILLARY BLOOD-CELL VELOCITY IN FINGERS

FAGRELL B; OSTERGREN J
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1982;1(2):163-171

THE INFLUENCE OF HYDROSTATIC-PRESSURE AND CONTRALATERAL COOLING ON CAPILLARY BLOOD-CELL VELOCITY AND TRANS-CUTANEOUS OXYGEN-TENSION IN FINGERS

FAGRELL B; SVEDMAN P; OSTERGREN J
Journal article: MICROVASCULAR RESEARCH. 1980;20(3):327-335

RELATIVE HEMATOCRIT IN HUMAN-SKIN CAPILLARIES AND ITS RELATION TO CAPILLARY BLOOD-FLOW VELOCITY

FAGRELL B; INTAGLIETTA M; OSTERGREN J
Visa fler

Alla övriga publikationer

Corrigendum: EUROPEAN HEART JOURNAL. 2014;35(27):1824

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (vol 34, pg 3035, 2013)

Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
Review: EUROPEAN HEART JOURNAL. 2013;34(28):2159-2219

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Rydén L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Review: LAKARTIDNINGEN. 2012;109(36):1544-1548

[Hypertension is a clinical problem ... even though we have tools to solve it].

Ostergren J
Letter: THROMBOSIS RESEARCH. 2010;125(5):473-474

Poor performance with a platelet counting technique to monitor clopidogrel inhibitory effects in the point-of-care setting

Malmstrom RE; Ostergren J; Jorgensen L; Hjemdahl P
Review: JOURNAL OF CLINICAL HYPERTENSION. 2009;11(2):66-73

Where Are We With the Management of Hypertension? From Science to Clinical Practice

Farsang C; Naditch-Brule L; Avogaro A; Oestergren J; Verdecchia P; Maggioni A; van de Borne P; Lins R; Roca-Cusachs A
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2008;9(1):205

LIPID LOWERING EFFICACY OF ROSUVASTATIN VS ATORVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE

Ostergren J; Malmstrom R; Jorgensen L; Walldius G
Review: EUROPEAN HEART JOURNAL SUPPLEMENTS. 2007;9(C):C3-C74

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text

Ryden L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jonsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Luis Zamorano J; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; GohIke H; Gonzalez Juanatey JR; Graham I; Monteiro PF; Parhofer K; Pyorala K; Raz I; Schernthaner G; Volpe M; Wood D
Editorial comment: DIABETES RESEARCH AND CLINICAL PRACTICE. 2007;76:S1-S2

Angiotensin receptor blockers in the prevention and management of diabetes and its complications -: Introduction

Ostergren J
Published conference paper: DIABETES RESEARCH AND CLINICAL PRACTICE. 2007;76:S13-S21

Renin-angiotensin-system blockade in the prevention of diabetes

Ostergren J
Review: EUROPEAN HEART JOURNAL. 2007;28(1):88-136

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary - The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

Ryden L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jonsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; Gohlke H; Juanatey JRG; Graham I; Monteiro PF; Parhofer K; Pyorala K; Raz I; Schernthaner G; Volpe M; Wood D
Review: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2006;7(2):64-73

From hypertension to heart failure -: Are there better primary prevention strategies?

Meredith PA; Oestergren J
Published conference paper: JOURNAL OF HYPERTENSION, SUPPLEMENT. 2006;24(1):S3-S7

Angiotensin receptor blockade with candesartan in heart failure:: findings from the Candesartan in Heart failure -: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Ostergren JB
Meeting abstract: JOURNAL OF CARDIAC FAILURE. 2004;10(4):S76

Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: Results of the CHARM low

Young JB; Swedberg K; Dunlap ME; Pfeffer MA; Probstfield JL; Granger CB; McKelvey RS; McMurray MJV; Michaelson EL; Olofsson B; Ostergren J; Yusuf S
Review: EXPERT OPINION ON PHARMACOTHERAPY. 2004;5(7):1589-1597

Candesartan for the treatment of hypertension and heart failure

Östergren J
Meeting abstract: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2004;43(5):a473

Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure

Yusuf S; Ostergren JB; Gerstein H; Pfeffer MA; Swedberg K; Granger CB; McMurray JJV
Published conference paper: DRUGS. 2004;64:43-60

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial -: Lipid lowering arm (ASCOT-LLA):: A multicentre randomised controlled trial

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J
Letter: HYPERTENSION. 2003;41(4):E5

Response:: HOPE not HYPE but mechanisms can be discussed

Svensson P; Östergren J
Editorial comment: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2002;24(1):4-5

Is there a need for the medical angiologist?

Östergren J; Fagrell B
Published conference paper: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2001;(117):19-21

Pharmaeoeconomic impact of HOPE

Östergren JB; Björholt I; Andersson F; Kahan T
Review: LAKARTIDNINGEN. 1999;96(13):1585-1590

[Intermittent claudication--a major cardiovascular risk factor. Proposed guidelines for investigation and treatment].

Svensson P; Wahlberg E; Hedin U; Ostergren J
Editorial comment: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 1998;:2

The role of ACE inhibitors in the prevention and treatment of atherosclerosis: a clinical approach - Introduction

Ostergren J
Visa fler

Anställningar

Projektledare, Lärande, Informatik, Management och Etik, Karolinska Institutet, 2024-2024

Examina och utbildning

Docent, Karolinska Institutet, 1988

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI